Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

CD47-Mediated Don’t-Eat-Me Signaling

ABSTRACT: This study explores high-risk plaques (HIP) in coronary artery disease, emphasizing CD47-mediated "Don't Eat Me" signaling and antioxidant responses, with implications for early detection and preventive therapies.

ORGANISM(S): Homo Sapiens (human)

SUBMITTER: Yasuhide Asaumi

PROVIDER: PXD057387 | JPOST Repository | Fri Oct 31 00:00:00 GMT 2025

REPOSITORIES: jPOST

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	F04_18_1ulkDIA3.raw	Raw
	F100_14_1ulkDIA3.raw	Raw
	F105_15_1ulkDIA1.raw	Raw
	F108_15_1ulkDIA2.raw	Raw
	F111_15_1ulkDIA3.raw	Raw

Items per page:

1 - 5 of 20

Similar Datasets

Proteomic Analysis of Carotid Artery Plaques With and Without Vulnerable Features on Magnetic Resonance Angiography with Vessel Wall Imaging: A Pilot Study

Project description:Single-center, cohort study of plaques identified with and without vulnerable features on magnetic resonance angiography with vessel wall imaging. Proteomic analysis of these plaques demonstrates different protein composition. These proteins may be used for early detection and intervention or as pharmacologic targets in patients with higher risk for stroke carotid artery disease.

2025-05-07 | PXD052120 | Pride

Transcription profiling of white and grey matter in the distribution on the middle cerebral artery 6 hours after administration of the saline/catalytic antioxidant AEOL 10150 and ischemia/reperfusion of the MCAO to study the effect of AEOL 10150 on gene expression.

Project description:A catalytic antioxidant (AEOL 10150) attenuates expression of inflammatory genes in stroke. White and grey matter in the distribution on the middle cerebral artery 6 hours after administration of the saline/catalytic antioxidant AEOL 10150 and ischemia/reperfusion of the MCAO; pooled mRNA from 6 brains.

2007-12-15 | E-GEOD-63 | biostudies-arrayexpress

Brain after ischemia and antioxidant

2002-06-26 | GSE63 | GEO

Molecular T-cell mediated rejection in transbronchial and mucosal lung transplant biopsies

Project description:We previously developed molecular assessment systems for lung transplant transbronchial biopsies (TBBs) with high surfactant and bronchial mucosal biopsies (3BMBs). Unsupervised machine learning identified T cell-mediated rejection (TCMR) based on expression of validated rejection-associated transcripts (RATs). The relationship to patient outcomes is not known. We aimed to establish whether molecular TCMR in TBBs and 3BMBs has implications for future graft loss. Molecular TCMR scores assigned in all TBBs or high surfactant TBBs agreed closely, indicating that variation in alveolar content in TBBs does not prevent detection of TCMR. Molecular assessments of 3BMB-3BMB pairs showed less variation than TBB-TBB pairs. TBB TCMR scores correlated with those in 3BMB. In both formats, molecular TCMR was associated with increased risk of graft loss whereas the presence of histologic rejection or donor-specific antibodies was not. Molecular TCMR can be detected in TBBs or 3BMBs and is associated with future risk of graft loss. TCMR emerges as a n important contributor to risk of failure. ClinicalTrials.gov NCT02812290.

2020-10-07 | GSE150156 | GEO

TP53-mediated clonal hematopoiesis confers increased risk for incident peripheral artery disease

Project description:TP53-mediated clonal hematopoiesis confers increased risk for incident peripheral artery disease

| PRJNA764590 | ENA

Transcriptome Analysis in Patients with Progressive Coronary Artery Disease

Project description:The identification of classic risk factors for coronary artery disease unveiled pathophysiologic mechanisms of atherosclerosis. Among them, inflammation as a systemic process measurable in peripheral blood plays a central role in plaque progression. However, other mechanisms of plaque progression remain to be fully understood. Therefore, this study sought to further investigate systemic correlates of plaque progression by global gene expression in peripheral blood. Microrarray gene expression analysis revealed 93 genes differentially expressed between the groups, of which 23 genes have no known function. Among the remaining 70 genes, 10 (14%) were identified to be associated with progenitor and pluripotent cells whereas only 3 genes (4%) had been associated with atherosclerosis. A risk prediction gene signature was developed by a multivariable statistical approach model integrating comprehensive laboratory and clinical patient data. This signature identified plaque progression with 81% sensitivity and 80% specificity (AUC: 0.86) for new patients, as estimated by resampling techniques. Array results were validated by qPCR for the genes ankyrin-2 (ANK2) and glutathione S-transferase theta 1 (GSTT1). In conclusion, patients with pogressive coronary artery disease despite good risk factor control exhibit particular gene expression patterns in peripheral blood. Understanding the functional implications of the observed changes might help to design new approaches to control atherosclerosis progression. From a large database of 45,727 coronary angiograms, peripheral blood was drawn from two patient groups with good risk factor control, but different clinical evolution: First, 16 patients with significant lesion progression leading to repeated coronary interventions and second, 16 patients with angiographically documented stable courses.

2012-11-30 | E-GEOD-34822 | biostudies-arrayexpress

Carnitine O-octanoyltransferase is a novel inducer of vascular calcification via promoting fatty acid metabolism and mitochondrial dysfunction

Project description:Objective – Vascular calcification is a critical pathology associated with increased cardiovascular event risk, but there are no FDA-approved anti-calcific therapies. We hypothesized and validated that an unbiased screening approach would identify novel mediators of human vascular calcification. Approach and Results – We performed an unbiased quantitative proteomics and pathway network analysis that identified increased carnitine O-octanoyltransferase (CROT) in calcifying primary human coronary artery smooth muscle cells (SMCs). Additionally, human carotid artery atherosclerotic plaques contained increased immunoreactive CROT near calcified regions. CROT siRNA reduced fibrocalcific response in calcifying SMCs. In agreement, histidine 327 to alanine point mutation inactivated human CROT fatty acid metabolism enzymatic activity and suppressed SMC calcification. CROT siRNA restored mitochondrial proteome alterations and suppressed mitochondrial fragmentation in calcifying SMCs. Lipidomics analysis of SMCs incubated with CROT siRNA revealed increased eicosapentaenoic acid, a vascular calcification inhibitor. CRISPR/Cas9-mediated Crot deficiency in low-density lipoprotein receptor-deficient mice reduced aortic and carotid artery calcification without altering bone density, or liver and plasma cholesterol and triglyceride concentrations. Conclusions – CROT is a novel inducer of vascular calcification via promoting fatty acid metabolism and mitochondrial dysfunction, as such CROT inhibition has strong potential as an anti-fibrocalcific therapy.

2021-02-26 | PXD022575 | Pride

Selenoprotein-Mediated Redox Regulation Shapes the Cell Fate of HSCs and Mature lineages [bulkRNA-seq]

Project description:The maintenance of cellular redox balance is crucial for cell survival and homeostasis and is disrupted with aging. Selenoproteins, comprising essential antioxidant enzymes, raise intriguing questions about their involvement in hematopoietic aging and potential reversibility. First, we observed a notable mRNA downregulation of key antioxidant selenoproteins in aged human hematopoietic stem cells (HSCs). Therefore, we employed tRNAsec gene (Trsp) knockout (KO) mouse model to simulate disrupted selenoprotein synthesis, revealing the insights into the protective roles of selenoproteins in preserving HSC stemness and facilitating B cell maturation, despite negligible effects on myeloid cells. Notably, Trsp KO exhibited B lymphocytopenia and reduced HSCs’ self-renewal capacity, reminiscent of aged phenotypes, along with the upregulation of aging-related genes in both HSCs and Pre-B cells. While Trsp KO activated an antioxidant response transcription factor NRF2 across all hematopoietic cells, we delineated a lineage-dependent phenotype driven by lipid peroxidation, which was exacerbated with aging yet ameliorated by ferroptosis inhibitors such as vitamin E. Interestingly, the myeloid genes were ectopically expressed in Pre-B cells of Trsp KO mice and the KO Pre-B/Pro-B cells displayed differentiation toward CD11b+ fraction in the transplant model, suggesting that disrupted selenoprotein synthesis induces the potential of B to myeloid switch. Collectively, our findings underscore the critical role of selenoprotein-mediated redox regulation in maintaining balanced hematopoiesis and highlight the preventive potential of selenoproteins against aging-related hematopoietic alterations.

2025-03-26 | GSE267189 | GEO

Selenoprotein-Mediated Redox Regulation Shapes the Cell Fate of HSCs and Mature lineages [scRNA-seq]

2025-03-26 | GSE267190 | GEO

High-throughput single-cell RNA-Seq profiling of DMSO-differentiated Huh7.5.1 undergoing or not long-term HCV infection

Project description:Hepatocellular carcinoma (HCC) is the second leading cause of cancer death worldwide, indicating urgent need for novel preventive strategies. Cancer chemoprevention discovery has been challenging due to the absence of tractable and clinically relevant model systems. Here, we developed a simple and robust human liver cell-based system, in which persistent hepatitis C virus (HCV) infection induces a HCC risk signature robustly predicting long-term HCC risk in cirrhotic patients. Using single-cell RNA-Seq analysis we observed a virus-dependent induction of the HCC high-risk gene signature and EGFR/MAPK signaling in HCV-infected liver cells. Our system, modeling the cell circuits encoded in the clinical HCC risk signature, enables investigation of the mechanisms of hepatocarcinogenesis and the discovery of cancer preventive strategies for HCC.

2021-07-01 | GSE81040 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data